These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23240173)

  • 1. Clinical presentation of meningococcal disease in childhood.
    Sabatini C; Bosis S; Semino M; Senatore L; Principi N; Esposito S
    J Prev Med Hyg; 2012 Jun; 53(2):116-9. PubMed ID: 23240173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococcal disease: clinical presentation and sequelae.
    Pace D; Pollard AJ
    Vaccine; 2012 May; 30 Suppl 2():B3-9. PubMed ID: 22607896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Invasive meningococcal disease--management and treatment].
    Garlicki A; Bociqga-Jasik M; Kalinowska-Nowak A
    Przegl Epidemiol; 2008; 62 Suppl 1():39-44. PubMed ID: 22320034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningococcal disease: the advances and challenges of meningococcal disease prevention.
    Yogev R; Tan T
    Hum Vaccin; 2011 Aug; 7(8):828-37. PubMed ID: 21832882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing protection against meningococcal disease.
    Reisinger KS; Black S; Stoddard JJ
    Clin Pediatr (Phila); 2010 Jun; 49(6):586-97. PubMed ID: 20089551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.
    Pace D
    Expert Rev Vaccines; 2009 May; 8(5):529-42. PubMed ID: 19397410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MenACWY-CRM, a novel quadrivalent glycoconjugate vaccine against Neisseria meningitidis for the prevention of meningococcal infection.
    Pace D
    Curr Opin Mol Ther; 2009 Dec; 11(6):692-706. PubMed ID: 20072946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and public health management of invasive meningococcal group W disease in the East Midlands region of England, United Kingdom, 2011 to 2013.
    Bethea J; Makki S; Gray S; MacGregor V; Ladhani S
    Euro Surveill; 2016 Jun; 21(24):. PubMed ID: 27336327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modern trends in mortality from meningococcal disease in Australia.
    Simpkins D; Wood N; Jelfs J; McIntyre PB; Menzies R; Lawrence G; Booy R
    Pediatr Infect Dis J; 2009 Dec; 28(12):1119-20. PubMed ID: 19858774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningococcal disease: risk for international travellers and vaccine strategies.
    Wilder-Smith A
    Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in vaccines to prevent meningococcal serogroup B infections.
    Vermont CL; van den Dobbelsteen GP; de Groot R
    Curr Opin Mol Ther; 2003 Feb; 5(1):33-8. PubMed ID: 12669468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal disease.
    Memish ZA; Alrajhi AA
    Saudi Med J; 2002 Mar; 23(3):259-64. PubMed ID: 11938412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of hospitalizations for meningococcal infection in Spain (1997-2008).
    Gil-Prieto R; García-García L; Alvaro-Meca A; González-Escalada A; Viguera Ester P; Gil De Miguel A
    Vaccine; 2011 Aug; 29(34):5765-70. PubMed ID: 21664402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. States act to prevent meningitis deaths.
    Breshears J
    NCSL Legisbrief; 2009; 17(19):1-2. PubMed ID: 19425280
    [No Abstract]   [Full Text] [Related]  

  • 15. MenACWY-TT vaccine for active immunization against invasive meningococcal disease.
    Papaevangelou V; Spyridis N
    Expert Rev Vaccines; 2012 May; 11(5):523-37. PubMed ID: 22827239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies.
    Sáfadi MA; McIntosh ED
    Expert Rev Vaccines; 2011 Dec; 10(12):1717-30. PubMed ID: 22085175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal disease and travel.
    Memish ZA
    Clin Infect Dis; 2002 Jan; 34(1):84-90. PubMed ID: 11731951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The implications of vaccines for prevention of bacterial meningitis.
    Riordan A
    Curr Opin Neurol; 2010 Jun; 23(3):319-24. PubMed ID: 20173637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter surveillance of invasive meningococcal infections in children.
    Kaplan SL; Schutze GE; Leake JA; Barson WJ; Halasa NB; Byington CL; Woods CR; Tan TQ; Hoffman JA; Wald ER; Edwards KM; Mason EO
    Pediatrics; 2006 Oct; 118(4):e979-84. PubMed ID: 17015517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningococcal disease.
    Daley AJ
    Aust Fam Physician; 2003 Aug; 32(8):597-601, 603-5. PubMed ID: 12973866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.